臺大學術典藏 |
2022-02-23T02:12:23Z |
Hepatitis C virus core antigen is cost-effective in community-based screening of active hepatitis C infection in Taiwan
|
Wang J.-H.; CHIEN-HUNG CHEN; Chang C.-M.; Feng W.-C.; Lee C.-Y.; Lu S.-N. |
臺大學術典藏 |
2022-02-22T05:34:12Z |
Hepatitis C virus core antigen is cost-effective in community-based screening of active hepatitis C infection in Taiwan
|
Wang J.-H.; CHIEN-HUNG CHEN; Chang C.-M.; Feng W.-C.; Lee C.-Y.; Lu S.-N. |
臺大學術典藏 |
2021-09-01T01:54:26Z |
OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma
|
Gao M.; Yeh P.Y.; Lu Y.-S.; Hsu C.-H.; Chen K.-F.; Lee W.-C.; Feng W.-C.; Chen C.-S.; Kuo M.-L.; ANN-LII CHENG |
臺大學術典藏 |
2021-09-01T01:54:12Z |
Induction of DNA damage-inducible gene GADD45β contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells
|
Ou D.-L.; Shen Y.-C.; Yu S.-L.; Chen K.-F.; Yeh P.-Y.; Fan H.-H.; Feng W.-C.; Wang C.-T.; Lin L.-I.; Hsu C.; ANN-LII CHENG |
臺大學術典藏 |
2021-09-01T01:54:11Z |
Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma
|
Chiang C.-T.; Yeh P.-Y.; Gao M.; Chen C.-W.; Yeh L.-C.; Feng W.-C.; Kuo S.-H.; Hsu C.-H.; Lu Y.-S.; ANN-LII CHENG |
臺大學術典藏 |
2021-09-01T01:54:10Z |
Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells
|
Chen K.-F.; Chen H.-L.; Tai W.-T.; Feng W.-C.; Hsu C.-H.; Chen P.-J.; ANN-LII CHENG |
臺大學術典藏 |
2021-08-31T06:29:42Z |
Inhibition of the Wnt/�]-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma
|
Lin H.-H.; Feng W.-C.; Lu L.-C.; Shao Y.-Y.; Hsu C.-H.; ANN-LII CHENG |
臺大學術典藏 |
2021-07-03T03:34:38Z |
Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells
|
Chen K.-F.; Chen H.-L.; Tai W.-T.; Feng W.-C.; Hsu C.-H.; PEI-JER CHEN; Cheng A.-L. |
臺大學術典藏 |
2021-03-15T07:44:45Z |
Inhibition of the Wnt/�]-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma
|
Lin H.-H.; Feng W.-C.; LI-CHUN LU; Shao Y.-Y.; Hsu C.-H.; Cheng A.-L. |
臺大學術典藏 |
2021-03-09T05:18:35Z |
Induction of DNA damage-inducible gene GADD45�] contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells
|
Ou D.-L.; Ying-Chun Shen; Yu S.-L.; Chen K.-F.; Yeh P.-Y.; Fan H.-H.; Feng W.-C.; Wang C.-T.; Lin L.-I.; Hsu C.; Cheng A.-L. |
臺大學術典藏 |
2021-02-23T08:26:33Z |
Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma
|
Chiang C.-T.;Yeh P.-Y.;Gao M.;Chen C.-W.;Yeh L.-C.;Feng W.-C.;Sung-Hsin Kuo;Hsu C.-H.;Lu Y.-S.;Cheng A.-L.; Chiang C.-T.; Yeh P.-Y.; Gao M.; Chen C.-W.; Yeh L.-C.; Feng W.-C.; SUNG-HSIN KUO; Hsu C.-H.; Lu Y.-S.; Cheng A.-L. |
臺大學術典藏 |
2020-07-03T08:45:47Z |
Induction of DNA damage-inducible gene GADD45�] contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells
|
Chen K.-F; Yu S.-L; Da-Liang Ou;Shen Y.-C;Yu S.-L;Chen K.-F;Yeh P.-Y;Fan H.-H;Feng W.-C;Wang C.-T;Lin L.-I;Hsu C;Cheng A.-L.; DA-LIANG OU; Shen Y.-C; Yeh P.-Y; Fan H.-H; Feng W.-C; Wang C.-T; Lin L.-I; Hsu C; Cheng A.-L. |
臺大學術典藏 |
2020-06-17T03:01:53Z |
Induction of DNA damage-inducible gene GADD45β contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells
|
Ou D.-L.;Shen Y.-C.;Sung-Liang Yu;Chen K.-F.;Yeh P.-Y.;Fan H.-H.;Feng W.-C.;Wang C.-T.;Lin L.-I.;Hsu C.;Cheng A.-L.; Ou D.-L.; Shen Y.-C.; SUNG-LIANG YU; Chen K.-F.; Yeh P.-Y.; Fan H.-H.; Feng W.-C.; Wang C.-T.; Lin L.-I.; Hsu C.; Cheng A.-L. |
臺大學術典藏 |
2020-05-25T06:52:04Z |
OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma
|
Cheng A.-L.;Kuo M.-L;Chen C.-S;Feng W.-C;Lee W.-C;Chen K.-F;Hsu C.-H;Yen-Shen Lu;Yeh P.Y;Gao M; Gao M; Yeh P.Y; YEN-SHEN LU; Hsu C.-H; Chen K.-F; Lee W.-C; Feng W.-C; Chen C.-S; Kuo M.-L; Cheng A.-L. |
臺大學術典藏 |
2020-05-25T06:52:01Z |
Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma
|
Chiang C.-T;Yeh P.-Y;Gao M;Chen C.-W;Yeh L.-C;Feng W.-C;Kuo S.-H;Hsu C.-H;Yen-Shen Lu;Cheng A.-L.; Chiang C.-T; Yeh P.-Y; Gao M; Chen C.-W; Yeh L.-C; Feng W.-C; Kuo S.-H; Hsu C.-H; YEN-SHEN LU; Cheng A.-L. |
臺大學術典藏 |
2020-04-28T07:25:27Z |
Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells
|
Chen K.-F. ;Chen H.-L. ;Tai W.-T. ;Feng W.-C. ;Chih-Hung Hsu ;Chen P.-J. ;Cheng A.-L.; Chen K.-F.; Chen H.-L.; Tai W.-T.; Feng W.-C.; CHIH-HUNG HSU; Chen P.-J.; Cheng A.-L. |
臺大學術典藏 |
2020-04-28T07:25:27Z |
Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma
|
Chiang C.-T.;Yeh P.-Y.;Gao M.;Chen C.-W.;Yeh L.-C.;Feng W.-C.;Kuo S.-H.;Chih-Hung Hsu;Lu Y.-S.;Cheng A.-L.; Chiang C.-T.; Yeh P.-Y.; Gao M.; Chen C.-W.; Yeh L.-C.; Feng W.-C.; Kuo S.-H.; CHIH-HUNG HSU; Lu Y.-S.; Cheng A.-L. |
臺大學術典藏 |
2020-04-28T07:25:18Z |
Integrated stable isotope labeling by amino acids in cell culture (SILAC) and isobaric tags for relative and absolute quantitation (iTRAQ) quantitative proteomic analysis identifies galectin-1 as a potential biomarker for predicting sorafenib resistance in liver cancer
|
Chow L.-P.; Feng W.-C.; Ho W.-C.; Tsai M.-H.; Shao Y.-Y.; CHIH-HUNG HSU; Yeh C.-C.; Yeh C.-C.;Chih-Hung Hsu;Shao Y.-Y.;Ho W.-C.;Tsai M.-H.;Feng W.-C.;Chow L.-P. |
臺大學術典藏 |
2020-04-10T12:51:17Z |
Induction of DNA damage-inducible gene GADD45β contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells
|
Shen Y.-C.; Ou D.-L.; Ou D.-L.;Shen Y.-C.;Yu S.-L.;Chen K.-F.;Yeh P.-Y.;Fan H.-H.;Feng W.-C.;Wang C.-T.;Lin L.-I.;Chiun Hsu;Cheng A.-L.; Cheng A.-L.; Yeh P.-Y.; Fan H.-H.; Feng W.-C.; Wang C.-T.; Lin L.-I.; Chiun Hsu; Chen K.-F.; Yu S.-L. |
臺大學術典藏 |
2020-04-10T12:16:03Z |
Integrated stable isotope labeling by amino acids in cell culture (SILAC) and isobaric tags for relative and absolute quantitation (iTRAQ) quantitative proteomic analysis identifies galectin-1 as a potential biomarker for predicting sorafenib resistance in liver cancer
|
Ho W.-C.; Tsai M.-H.; Feng W.-C.; Chow L.-P.; Hsu C.-H.; YU-YUN SHAO; Yeh C.-C.;Hsu C.-H.;Yu-Yun Shao;Ho W.-C.;Tsai M.-H.;Feng W.-C.;Chow L.-P.; Yeh C.-C. |
臺大學術典藏 |
2020-04-10T12:16:00Z |
Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma
|
Lin H.-H.; Feng W.-C.; Lu L.-C.; YU-YUN SHAO; Hsu C.-H.; Cheng A.-L. |
臺大學術典藏 |
2020-02-10T09:00:19Z |
Integrated stable isotope labeling by amino acids in cell culture (SILAC) and isobaric tags for relative and absolute quantitation (iTRAQ) quantitative proteomic analysis identifies galectin-1 as a potential biomarker for predicting sorafenib resistance in liver cancer
|
Yeh C.-C.;Hsu C.-H.;Shao Y.-Y.;Ho W.-C.;Tsai M.-H.;Feng W.-C.;Chow L.-P.; Yeh C.-C.; Hsu C.-H.; Shao Y.-Y.; Ho W.-C.; Tsai M.-H.; Feng W.-C.; Chow L.-P.; MONG-HSUN TSAI |
臺大學術典藏 |
2020-01-22T04:47:49Z |
Integrated stable isotope labeling by amino acids in cell culture (SILAC) and isobaric tags for relative and absolute quantitation (iTRAQ) quantitative proteomic analysis identifies galectin-1 as a potential biomarker for predicting sorafenib resistance in liver cancer
|
Yeh C.-C.;Hsu C.-H.;Shao Y.-Y.;Ho W.-C.;Tsai M.-H.;Feng W.-C.;Lu-Ping Chow; Yeh C.-C.; Hsu C.-H.; Shao Y.-Y.; Ho W.-C.; Tsai M.-H.; Feng W.-C.; LU-PING CHOW |
國立成功大學 |
2018 |
Disease and economic burden for rare diseases in Taiwan: A longitudinal study using Taiwan’s National Health Insurance Research Database
|
Hsu, J.C.;Wu, H.-C.;Feng, W.-C.;Chou, Chou C.-H.;Lai, E.C.-C.;Lu, C.Y. |
國立臺灣大學 |
2012 |
SYNERGISTIC ANTI-TUMOR EFFECT OF SORAFENIB IN COMBINATION WITH AKT INHIBITORS IN HEPATOCELLULAR CARCINOMA
|
Feng, W. -C.; Hsu, C. -H.; Lin, S. -D.; Lin, H. -H.; Hsu, D. -W.; Huang, C. -C.; Chow, L. -P.; Cheng, A. -L.; 周綠蘋; 鄭安理; 徐志宏 |